Earnings Ahead

HZNP - Horizon Pharma Inc

Horizon Pharma Inc

Horizon Pharma Inc

About

Profile


Headquarters

Dublin 4


Intraday

High
-
Low
-

52-week

High
-
Low
-

HZNP



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Horizon Therapeutics Non-GAAP EPS of $1.20 beats by $0.23, revenue of $945M beats by $71.49M
  • Horizon Therapeutics Q2 2023 Earnings Preview
  • 2023 shaping up to be biggest year for biopharma M&A since pandemic
  • Amgen says FTC has ignored commitments it made to address Horizon deal concerns (update)
  • Horizon lupus asset daxdilimab misses primary endpoint in phase 2
  • Tepezza warning label unlikely to have any impact on Horizon/Amgen deal - analyst
  • Key Horizon drug Tepezza has hearing loss warning added to labeling
  • Amgen, FTC said there are no ongoing talks, though open to settlement over Horizon
  • Eli Lilly, Merck among top pharma picks in Barclays Q2 preview
  • Catalyst Watch: Microsoft-Activision Blizzard drama, Splunk event and Nasdaq 100 rebalancing countdown
  • iRobot, Seagen, Horizon gain amid Microsoft win in Activision case
  • Goldman Sachs sees rays of hope in underperforming health sector
  • New M&A rules likely to delay deals by months, add significant costs
  • Pfizer sees second request as likely in FTC's review of Seagen deal - analyst
  • What is behind big pharma's underperformance?
  • FTC files suit with ALJ on Horizon/Amgen deal (update)
  • Amgen had settlement talks with FTC over Horizon, though no agreement - report
  • Six states join FTC lawsuit to block Amgen's planned purchase of Horizon
  • BTIG starts Virdian at buy, cites market potential for thyroid eye drug
  • Seagen gains as antitrust deadline for Pfizer purchase nears on Monday
PEERS
/XLV

XLV

Earnings History

Date EPS / Forecast Revenue / Forecast
November 3, 2021 1.75 / 1.54 1.04B / 979.49M
August 4, 2021 1.62 / 0.8706 832.55M / 703.83M Beat!
May 5, 2021 0.03 / 0.0476 342.41M / 326.29M Beat!
February 24, 2021 1.28 / 1.06 745.3M / 693.57M Beat!
November 2, 2020 1.74 / 0.9675 636.43M / 531.12M Beat!
August 5, 2020 0.4 / 0.36 462.8M / 333.7M Beat!
May 6, 2020 0.4 / 0.21 355.9M / 287.88M Beat!
February 26, 2020 0.56 / 0.42 363.5M / 349.25M Beat!
November 6, 2019 0.64 / 0.5 335.47M / 330.56M Beat!
August 7, 2019 0.49 / 0.37 320.6M / 296.25M Beat!
May 8, 2019 0.3 / 0.12 280.4M / 238.46M Beat!
February 27, 2019 0.67 / 0.54 355.54M / 334.19M Beat!
November 7, 2018 0.65 / 0.49 325.31M / 311.84M Beat!
August 8, 2018 0.48 / 0.31 302.8M / 275.5M Beat!
May 9, 2018 0.03 / 0.06 223.88M / 233.37M
February 5, 2018 - / 0.22 - / 266.8M
November 6, 2017 0.26 / 0.22 271.6M / 259.7M Beat!
August 7, 2017 0.41 / 0.21 289.5M / 237.0M Beat!
May 8, 2017 0.21 / 0.12 220.9M / - Beat!
February 27, 2017 0.64 / 0.24 310.4M / 307.9M Beat!
November 7, 2016 0.7 / 0.5 208.7M / 272.0M
Date Price Open High Low Vol Change ER
Mar 4 99.38 97.66
99.77
97.40
2.11M 1.44%
Mar 3 97.97 98.37
98.66
96.48
1.48M -0.35%
Mar 2 98.31 96.97
99.95
96.24
2.44M 1.28%
Mar 1 97.07 94.26
98.57
94.02
3.01M 6.47%
Feb 28 91.17 93.57
93.60
89.43
3.71M -3.02%
 
Feb 25 94.01 92.82
94.30
92.09
2.89M 1.28%
Feb 24 92.82 88.96
93.20
88.35
2.35M 1.49%
Feb 23 91.46 93.66
94.02
91.36
1.82M -1.4%
Feb 22 92.76 92.51
93.63
92.06
1.48M -0.65%
Feb 18 93.37 94.50
95.29
92.20
2.09M -1.05%
Feb 17 94.36 97.01
97.64
93.93
3.68M -3.42%
Feb 16 97.70 97.78
98.23
96.75
1.80M -0.48%
Feb 15 98.17 98.15
99.13
97.16
1.43M 1.74%
Feb 14 96.49 96.27
97.65
95.76
2.65M -0.17%
Feb 11 96.65 97.07
97.99
95.85
2.32M -0.42%
Feb 10 97.06 96.50
98.77
96.50
2.25M -0.35%
Feb 9 97.40 96.17
97.66
95.97
1.24M 2.53%
Feb 8 95.00 93.08
95.04
92.33
1.52M 1.31%
Feb 7 93.77 92.73
94.72
92.55
985.65K 1.32%